Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

The relationship between obesity and atherosclerotic progression and prognosis among patients with coronary artery bypass grafts the effect of aggressive statin therapy.

Wee CC, Girotra S, Weinstein AR, Mittleman MA, Mukamal KJ.

J Am Coll Cardiol. 2008 Aug 19;52(8):620-5. doi: 10.1016/j.jacc.2008.05.021.

2.

Alcohol consumption, atherosclerotic progression, and prognosis among patients with coronary artery bypass grafts.

Mukamal KJ, Girotra S, Mittleman MA.

Am Heart J. 2006 Feb;151(2):368-72.

PMID:
16442902
3.

Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators.

Knatterud GL, Rosenberg Y, Campeau L, Geller NL, Hunninghake DB, Forman SA, Forrester JS, Gobel FL, Herd JA, Hickey A, Hoogwerf BJ, Terrin ML, White C.

Circulation. 2000 Jul 11;102(2):157-65.

4.

Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators.

Domanski MJ, Borkowf CB, Campeau L, Knatterud GL, White C, Hoogwerf B, Rosenberg Y, Geller NL.

J Am Coll Cardiol. 2000 Nov 15;36(6):1877-83.

5.

Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial.

White CW, Gobel FL, Campeau L, Knatterud GL, Forman SA, Forrester JS, Geller NL, Herd JA, Hickey A, Hoogwerf BJ, Hunninghake DB, Rosenberg Y, Terrin ML; Post Coronary Artery Bypass Graft Trial Investigators..

Circulation. 2001 Nov 27;104(22):2660-5.

6.

Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.

Hoogwerf BJ, Waness A, Cressman M, Canner J, Campeau L, Domanski M, Geller N, Herd A, Hickey A, Hunninghake DB, Knatterud GL, White C.

Diabetes. 1999 Jun;48(6):1289-94.

PMID:
10342818
7.

Relation of heart rate response to exercise with prognosis and atherosclerotic progression after coronary artery bypass grafting.

Girotra S, Keelan M, Weinstein AR, Mittleman MA, Mukamal KJ.

Am J Cardiol. 2009 May 15;103(10):1386-90. doi: 10.1016/j.amjcard.2009.01.346. Epub 2009 Mar 25.

PMID:
19427433
8.

Effect of pravastatin on progression of coronary atherosclerosis in patients after coronary artery bypass surgery.

Makuuchi H, Furuse A, Endo M, Nakamura H, Daida H, Watanabe M, Ohashi Y, Hosoda Y, Hosoda S, Yamaguchi H, Yasui H.

Circ J. 2005 Jun;69(6):636-43.

9.

Is aggressive cholesterol control justified? Review of the post-coronary artery bypass graft trial.

Hunninghake DB.

Am J Cardiol. 1998 Nov 26;82(10B):45T-48T. Review.

PMID:
9860374
10.

Pleiotropic effect of lovastatin, with and without cholestyramine, in the post coronary artery bypass graft (Post CABG) trial.

Domanski M, Tian X, Fleg J, Coady S, Gosen C, Kirby R, Sachdev V, Knatterud G, Braunwald E.

Am J Cardiol. 2008 Oct 15;102(8):1023-7. doi: 10.1016/j.amjcard.2008.05.053. Epub 2008 Aug 9.

PMID:
18929703
11.

Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators.

Campeau L, Hunninghake DB, Knatterud GL, White CW, Domanski M, Forman SA, Forrester JS, Geller NL, Gobel FL, Herd JA, Hoogwerf BJ, Rosenberg Y.

Circulation. 1999 Jun 29;99(25):3241-7.

12.

Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety.

Kulik A, Ruel M.

Expert Opin Drug Saf. 2009 Sep;8(5):559-71. doi: 10.1517/14740330903188413. Review.

PMID:
19673591
13.

Moderate alcohol consumption and safety of lovastatin and warfarin among men: the post-coronary artery bypass graft trial.

Mukamal KJ, Smith CC, Karlamangla AS, Moore AA.

Am J Med. 2006 May;119(5):434-40.

PMID:
16651056
14.

Perioperative statin therapy is associated with a significant and dose-dependent reduction of adverse cardiovascular outcomes after coronary artery bypass graft surgery.

Ouattara A, Benhaoua H, Le Manach Y, Mabrouk-Zerguini N, Itani O, Osman A, Landi M, Riou B, Coriat P.

J Cardiothorac Vasc Anesth. 2009 Oct;23(5):633-8. doi: 10.1053/j.jvca.2009.02.008. Epub 2009 Apr 10.

PMID:
19362495
15.

Effects of body mass index on early outcome of coronary artery bypass surgery.

Shirzad M, Karimi A, Armadi SH, Marzban M, Abbasi K, Alinejad B, Moshtaghi N.

Minerva Chir. 2009 Feb;64(1):17-23.

PMID:
19202532
16.

Lipid lowering and coronary bypass graft surgery.

Campeau L.

Curr Opin Cardiol. 2000 Nov;15(6):395-9. Review.

PMID:
11198621
17.

Prediction of native coronary artery disease progression following PTCA or CABG in the Emory Angioplasty Versus Surgery Trial.

Zhao XQ, Kosinski AS, Barnhart HX, Superko HR, King SB 3rd.

Med Sci Monit. 2003 Feb;9(2):CR48-54.

PMID:
12601286
18.

Relationship of body mass index with outcomes after coronary artery bypass graft surgery.

Wagner BD, Grunwald GK, Rumsfeld JS, Hill JO, Ho PM, Wyatt HR, Shroyer AL.

Ann Thorac Surg. 2007 Jul;84(1):10-6.

PMID:
17588373
20.

Effects of aggressive statin therapy on patients with coronary saphenous vein bypass grafts: a systematic review and meta-analysis of randomized, controlled trials.

Kang S, Liu Y, Liu XB.

Clin Ther. 2013 Aug;35(8):1125-36. doi: 10.1016/j.clinthera.2013.06.006. Epub 2013 Aug 7. Review.

PMID:
23932462

Supplemental Content

Support Center